SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
21 07 2023
Historique:
accepted: 08 06 2023
revised: 24 05 2023
received: 22 09 2022
medline: 7 9 2023
pubmed: 13 6 2023
entrez: 13 6 2023
Statut: ppublish

Résumé

The Sirtuin family of NAD+-dependent enzymes plays an important role in maintaining genome stability upon stress. Several mammalian Sirtuins have been linked directly or indirectly to the regulation of DNA damage during replication through Homologous recombination (HR). The role of one of them, SIRT1, is intriguing as it seems to have a general regulatory role in the DNA damage response (DDR) that has not yet been addressed. SIRT1-deficient cells show impaired DDR reflected in a decrease in repair capacity, increased genome instability and decreased levels of γH2AX. Here we unveil a close functional antagonism between SIRT1 and the PP4 phosphatase multiprotein complex in the regulation of the DDR. Upon DNA damage, SIRT1 interacts specifically with the catalytical subunit PP4c and promotes its inhibition by deacetylating the WH1 domain of the regulatory subunits PP4R3α/β. This in turn regulates γH2AX and RPA2 phosphorylation, two key events in the signaling of DNA damage and repair by HR. We propose a mechanism whereby during stress, SIRT1 signaling ensures a global control of DNA damage signaling through PP4.

Identifiants

pubmed: 37309898
pii: 7195028
doi: 10.1093/nar/gkad504
pmc: PMC10359614
doi:

Substances chimiques

Phosphoric Monoester Hydrolases EC 3.1.3.2
Sirtuin 1 EC 3.5.1.-
protein phosphatase 4 EC 3.1.3.16

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6754-6769

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

J Biol Chem. 1999 Feb 26;274(9):5339-47
pubmed: 10026142
Mol Cell Proteomics. 2005 Nov;4(11):1725-40
pubmed: 16085932
J Biol Chem. 2006 Dec 22;281(51):39517-33
pubmed: 17035231
Elife. 2020 Jan 29;9:
pubmed: 31995034
Nucleic Acids Res. 2013 Jun;41(11):e115
pubmed: 23585275
Methods Mol Biol. 2013;1077:273-83
pubmed: 24014413
Cell Cycle. 2007 Dec 1;6(23):2869-71
pubmed: 18156798
Mol Cell. 2023 Jan 5;83(1):12-25.e10
pubmed: 36543171
Elife. 2020 Jun 15;9:
pubmed: 32538779
Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1336-43
pubmed: 22665577
NPJ Breast Cancer. 2019 Aug 8;5:23
pubmed: 31428676
Cancer Cell. 2008 Oct 7;14(4):312-23
pubmed: 18835033
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Int J Mol Sci. 2020 Jan 10;21(2):
pubmed: 31936707
J Mol Cell Biol. 2012 Oct;4(5):294-303
pubmed: 22735644
Cell Res. 2008 Sep;18(9):974-7
pubmed: 19160544
Biochem J. 2000 May 1;347 Pt 3:845-55
pubmed: 10769191
Cell Commun Signal. 2010 Sep 22;8:27
pubmed: 20860841
Annu Rev Pathol. 2010;5:253-95
pubmed: 20078221
EMBO Rep. 2008 Oct;9(10):1019-26
pubmed: 18758438
Nat Struct Mol Biol. 2010 Mar;17(3):365-72
pubmed: 20154705
Protein Expr Purif. 2003 Sep;31(1):19-33
pubmed: 12963337
FEBS J. 2015 May;282(9):1745-67
pubmed: 25223884
J Physiol Biochem. 2016 Sep;72(3):371-80
pubmed: 27154583
Mol Cell. 2019 Dec 19;76(6):953-964.e6
pubmed: 31585692
FEBS Lett. 2005 Jun 13;579(15):3278-86
pubmed: 15913612
Mol Cytogenet. 2022 Jun 14;15(1):23
pubmed: 35701783
Mol Cell. 2011 Apr 22;42(2):210-23
pubmed: 21504832
Nat Cell Biol. 2003 Jul;5(7):675-9
pubmed: 12792649
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
Cell Cycle. 2012 Jul 15;11(14):2590-1
pubmed: 22751432
J Biochem. 2014 Aug;156(2):85-95
pubmed: 24682951
Tumour Biol. 2016 Sep;37(9):11893-11901
pubmed: 27059736
Mol Cell. 2007 Jul 6;27(1):149-62
pubmed: 17612497
PLoS One. 2009 Dec 22;4(12):e8414
pubmed: 20027304
Sci Signal. 2014 Jul 29;7(336):ra71
pubmed: 25074979
Cell Cycle. 2012 Jul 15;11(14):2643-9
pubmed: 22732494
Cell Rep. 2017 Nov 21;21(8):2048-2057
pubmed: 29166597
Cancers (Basel). 2018 Oct 30;10(11):
pubmed: 30380732
Radiat Res. 2002 Oct;158(4):486-92
pubmed: 12236816
EMBO J. 2012 May 16;31(10):2403-15
pubmed: 22491012
Carcinogenesis. 2010 Jun;31(6):994-1002
pubmed: 20130019
Mol Cancer. 2015 Apr 28;14:95
pubmed: 25927939
Nucleic Acids Res. 2017 Jul 27;45(13):7807-7824
pubmed: 28549174
PLoS One. 2008;3(12):e4020
pubmed: 19107194
BMB Rep. 2020 Apr;53(4):181-190
pubmed: 32192570
Methods Mol Biol. 2007;365:23-38
pubmed: 17200551
Mol Cell. 2008 Jul 11;31(1):33-46
pubmed: 18614045
N Engl J Med. 2011 Jun 9;364(23):2235-44
pubmed: 21651395
Biochem Biophys Res Commun. 2009 Dec 25;390(4):1355-60
pubmed: 19895790
J Exp Clin Cancer Res. 2016 Dec 5;35(1):182
pubmed: 27916001
Exp Mol Med. 2007 Feb 28;39(1):8-13
pubmed: 17334224
Ann Lab Med. 2020 Mar;40(2):114-121
pubmed: 31650727
J Biol Chem. 2012 Jul 6;287(28):23489-501
pubmed: 22553202
Mol Cell. 2013 Aug 22;51(4):454-68
pubmed: 23911928
J Biol Chem. 2010 Apr 23;285(17):13223-32
pubmed: 20167603
PLoS One. 2015 Apr 23;10(4):e0123935
pubmed: 25905708
EMBO J. 2016 Jul 15;35(14):1488-503
pubmed: 27225932
FEBS Lett. 2002 Feb 20;513(1):45-52
pubmed: 11911879
Curr Biol. 2002 Oct 29;12(21):1846-51
pubmed: 12419185
Int J Biol Sci. 2009;5(2):147-52
pubmed: 19173036
Nat Neurosci. 2013 Aug;16(8):1008-15
pubmed: 23852118
Cell Metab. 2016 Oct 11;24(4):526-528
pubmed: 27732834
Nature. 2007 Nov 15;450(7168):440-4
pubmed: 18004385
Trends Cell Biol. 2014 Feb;24(2):108-17
pubmed: 24094932
Int J Biol Sci. 2014 Nov 26;10(10):1193-202
pubmed: 25516717
Mol Cell. 2014 Dec 4;56(5):681-95
pubmed: 25454945
Open Biol. 2020 Dec;10(12):200343
pubmed: 33352067
Nat Commun. 2019 Sep 18;10(1):4252
pubmed: 31534152
J Biol Chem. 2001 Nov 9;276(45):42462-7
pubmed: 11571274
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Genes Dev. 2020 Jan 1;34(1-2):7-23
pubmed: 31896689
J Biol Chem. 2008 Mar 21;283(12):7590-8
pubmed: 18203716
Cell. 2020 Nov 25;183(5):1436-1456.e31
pubmed: 33212010

Auteurs

George Rasti (G)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Maximilian Becker (M)

Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Berta N Vazquez (BN)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Maria Espinosa-Alcantud (M)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Irene Fernández-Duran (I)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.

Andrés Gámez-García (A)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.

Alessandro Ianni (A)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Department of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Ludwigstrasse 43, 61231Bad Nauheim, Germany.

Jessica Gonzalez (J)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Laia Bosch-Presegué (L)

Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IrisCC). Experimental Sciences and Methodology Department. Faculty of Health Sciences and Welfare (FCSB), University of Vic - Central University of Catalonia (UVic-UCC), Vic, Spain.

Anna Marazuela-Duque (A)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Anna Guitart-Solanes (A)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.

Sandra Segura-Bayona (S)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Current affiliation: The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Joan-Josep Bech-Serra (JJ)

Proteomic Unit, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916, Badalona, Barcelona, Spain.

Michael Scher (M)

Howard Hughes Medical Institute, Division of Nucleic Acids Enzymology, Department of Biochemistry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, NJ08854, USA.

Lourdes Serrano (L)

Department of Science, BMCC, The City University of New York (CUNY), 199 Chambers Street N699P, New Yirk, NY10007, USA.

Uma Shankavaram (U)

Radiation Oncology Branch, National Cancer Institute, Bethesda, MD20892, USA.

Hediye Erdjument-Bromage (H)

Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY10065, USA.
Department of Cell Biology, New York University School of Medicine, New York, NY10016, USA.

Paul Tempst (P)

Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY10065, USA.

Danny Reinberg (D)

Howard Hughes Medical Institute, Division of Nucleic Acids Enzymology, Department of Biochemistry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, NJ08854, USA.
Howard Hughes Medical Institute, Department of Biochemistry, New York University School of Medicine, New York, NY10016, USA.

Mireia Olivella (M)

Bioinfomatics and Medical Statistics Group, Faculty of Science, Technology and Engineering. University of Vic-Central University of Catalonia, Vic, Spain.

Travis H Stracker (TH)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Radiation Oncology Branch, National Cancer Institute, Bethesda, MD20892, USA.

Carolina de la Torre (C)

Proteomic Unit, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916, Badalona, Barcelona, Spain.

Alejandro Vaquero (A)

Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH